Back in February(!) the CEO was confident they would get the first patient dose sales in Europe in the first half of this year. It would be nice to get an update on this, preferably before the annual report which isn't due until mid August.
As a side note Bell Potter, who previously had a Buy recommendation and a PT of 25c seem to have quietly ceased coverage,
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
0.020(2.00%) |
Mkt cap ! $14.50M | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.02 | 99.5¢ | $38.97K | 38.98K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6000 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.04 | 6250 | 1 |
View Market Depth
| Last trade - 13.40pm 25/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |